Product
Dextromethorphan
Aliases
Robitussin
14 clinical trials
18 indications
Indication
Advanced Solid TumorIndication
MalariaIndication
HealthyIndication
Healthy SubjectsIndication
Schizophrenia, Treatment ResistantIndication
Major Depressive DisorderIndication
Interaction Drug FoodIndication
Obsessive-Compulsive DisorderIndication
Illness Anxiety DisorderIndication
Body Dysmorphic DisorderIndication
Somatic Symptom DisorderIndication
AfricanIndication
TrypanosomiasisIndication
Postoperative PainIndication
FibromyalgiaIndication
PrimaryIndication
Irritable MoodIndication
Food-drug InteractionClinical trial
A Two-cohort, Two-part, Phase 1, Multicenter, Open-label, Fixed-sequence, Drug-Drug Interaction and QTc Assessments of Sitravatinib Followed by Combination Treatment With Nivolumab in Patients With Advanced Solid MalignanciesStatus: Completed, Estimated PCD: 2022-12-22
Clinical trial
A Phase I, Open-label, Fixed-sequence, Two-period, Crossover, Drug-drug Interaction Study to Evaluate the Effect of Multiple Doses of Ganaplacide and Lumefantrine Combination on the Pharmacokinetics of Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir in Healthy ParticipantsStatus: Completed, Estimated PCD: 2022-10-17
Clinical trial
Evaluation of the Effect of LY3871801 on the Pharmacokinetics of CYP450 Substrates and an OAT1/3 Substrate in Healthy ParticipantsStatus: Completed, Estimated PCD: 2023-03-29
Clinical trial
The Effect of Imlunestrant on CYP2C8, CYP2C19, CYP2D6, P-gp, and BCRP Activity and the Effect of P-gp Inhibition on Imlunestrant Pharmacokinetics in Healthy Women of Non-childbearing PotentialStatus: Completed, Estimated PCD: 2022-11-02
Clinical trial
An Open-label, 2-cycle Clinical Study to Evaluate the Drug Interaction Between Itraconazole or Dextromethorphan and IBI351 in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-10-16
Clinical trial
Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia: A Randomized, Group Sequential Adaptive Design, Controlled Clinical TrialStatus: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder: A Randomized, Group Sequential, Adaptive Design, Controlled Clinical TrialStatus: Completed, Estimated PCD: 2023-09-30
Clinical trial
Assessing the Pharmacokinetics and Drug Interaction Liability of Kratom, an Opioid-like Natural ProductStatus: Completed, Estimated PCD: 2021-08-31
Clinical trial
Fluoxetine/Dextromethorphan in Obsessive-Compulsive and Related Disorders: an Open-Label Crossover Pilot StudyStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
Single Centre Open-label, Non-randomised, 3-treatment, 2-period, Pharmacokinetic Drug Interaction Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorphan in Healthy Male ParticipantsStatus: Completed, Estimated PCD: 2023-05-03
Clinical trial
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Perioperative Dextromethorphan Compared to Placebo for the Treatment of Postoperative PainStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Psilocybin-facilitated Treatment for Chronic PainStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
The Study of Risk Factors and Intervention for Children With Chronic Irritability - a Preliminary Approach With Epidemiological, Neuropsychological and Neuroinflammation StudiesStatus: , Estimated PCD: 2024-04-05
Clinical trial
Licorice Botanical Dietary Supplements - Metabolism and Safety in WomenStatus: Completed, Estimated PCD: 2020-07-31